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Executive Summary
Background
The emergency contraception pill (ECP) is an important method of contraception
which can be used after sex to prevent unintended pregnancy in case a method is not
used or has failed. Considering the high rate of unwanted pregnancy in India, the ECP
was introduced in the National Family Planning Program in 2002 and made Over the
Counter (OTC) drug in 2005. Evidence shows a very low knowledge and use of ECP.
Providers' attitudes and lack of media coverage appear to be barriers to access and use
of ECP. Moreover, ever since ECP has been made available as an OTC, there have been
concerns that it may be misused leading to repeated use, increase in premarital sex and
promiscuity, replacement of other regular family planning methods.

Objectives
The Population Council undertook this study to assess the knowledge, attitudes, and
practices regarding ECP among providers in public and private facilities and
pharmacies. The objectives of the study were to:
·

Assess providers' knowledge of ECP's biological mechanism;

·

Understand providers' knowledge and attitudes about ECP's safety,
effectiveness, and availability as an OTC drug;

·

Identify providers' definitions of 'repeated use' and profiling women who are
'repeated users' of ECP.

Methodology
A quantitative survey was conducted in four cities of Uttar Pradesh (Agra, Lucknow,
Kanpur and Aligarh) and Delhi covering 315 providers (199 pharmacists, 83
gynecologists and 33 paramedics). The qualitative interviews of 19 experts (eight
gynecologists, seven government officials at MoHFW, three development organization
officials and one ECP manufacturing firm professional) referred to as key opinion
leaders were carried out.

Key findings
·

Doctors (96 percent) knew that the mechanism of ECP prevents pregnancy
(prevents implantation) whereas many paramedics (40 percent) and most
pharmacists (61 percent) lacked this knowledge. Eighty Four percent
providers believed that ECP is a safe and effective method.

·

There were some misconceptions such as; ECP cannot be used by women
with heart problems or while breastfeeding, ECP can have serious side effects.
vii

·

Many providers also showed negative attitudes which act as a barrier towards
accessibility of ECP. More doctors than other providers disapprove ECP as
OTC drug. Most favored minimum age restriction to provide ECP and
believed ECP will promote promiscuity. Doctors held stronger negative
attitudes towards ECP use and ECP provision by CHWs and ANMs.

·

Favourable attitude was found among those who were trained in ECP or had
read literature on ECP. A logistic regression showed that younger, trained and
male providers were more likely to support ECP provision in comparison to
older, untrained and female providers.

·

Repeat use came up as an important issue related to OTC availability of ECP.
There was confusion among KOLs and providers on what counts as repeated
use. Most providers said that ECP used 2-3 times within same cycle is
considered repeated use and discouraged repeated use. Sixty to 75 percent
believed that ECP is being used repeatedly.

Way forward
This study's findings revealed many biases and gaps in knowledge, lack of training,
moral reservations and misuse. These can be used to develop programs to increase
knowledge and access to ECP. An advocacy strategy including an educational campaign
is needed to tackle the negative attitudes of doctors and other stakeholders.
The Government should remove the current ban on ECP advertising but provide
guidelines to manufacturers for their advertisements so that careful advertisements
which promote ECP to be used in emergency only can be broadcasted. In all
advertisements of condoms and pills, ECP should be added as a backup support.
Companies who advertise their ECP brand on TV and newspapers should also
mention that it is not a regular contraceptive method.

viii

A pharmacy crowded by customers in New Delhi

Nurse in a post-partum center talking with client about family
planning methods
ix

A chemist shop located near one of the largest hospitals in New Delhi

Panelists from the public sector and medical associations at a consultation
meeting in New Delhi
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Introduction
The Emergency Contraception Pill (ECP) is a hormone-based method providing a
woman with an opportunity for preventing unwanted pregnancy after intercourse
(Camp, Wilkerson & Raine, 2003; Croxatto et al., 2004; Hossain-Sharif, Khan,
Sebastian & Roychowdhury, 2008). ECP is an important component of the range of
contraceptive services in India, where unmet family planning (FP) need is about 21.3
percent (IIPS, 2010). Several research studies across the globe have shown that ECP is
safe, convenient to use, and can be effective in preventing unwanted pregnancies
(WHO & JHUCCP 2011). Findings from these research studies have encouraged
several countries, including India, to make ECP available “over the counter” (OTC),
without prescription.
In India, ECP was approved and introduced into the National Family Planning
Program in 2002, and made an OTC drug in 2005. As an OTC drug, ECP can also be
stocked and distributed by paramedics and community health workers (CHWs).
Subsequently, it has been made available by government as well as non- governmental
organizations along with existing contraceptives and promoted as a product that could
be given in case of emergency. Data from the District Level Household and Facility
Survey (IIPS, 2010) show that less than 1 percent (0.5 percent of rural and 0.8 percent
of urban) of married women have ever used ECP. Furthermore, less than one-third of
surveyed unmarried women knew about ECP. Awareness among currently married
rural women was much lower, at 24 percent, compared to urban women at 47 percent
(IIPS, 2010). Another study during the same period (Puri et al., 2007) among female
college students from Chandigarh in northern India reported only 7.3 percent of 1,017
students knowing that ECP exists. A more recent study in a medical college among a
smaller sample of 300 students largely from the rural population of Uttar Pradesh (UP)
showed even lower (2 percent) knowledge (Nigam, Maheshwari & Prakash, 2010). A
recent study by Population Council in rural Bihar found that 5 percent women were
aware of ECP, and less than 1 percent had ever used it (Bhatnagar & Khan, 2011).
Several individual, community and system barriers contribute to limited ECP
awareness and use, including lack of accurate knowledge of its mechanism and
providers' religious affiliations and fear that wide ECP availability may lead to increased
sexual partners or early initiation of sex (Aksu, Basak, Yeniceri & Kaya, 2011; Rubin,
Grumet & Prine, 2006; Sychareun, Phongsavan, Hansana & Phengsavanh, 2010).
Further studies have shown that providers believe easy access to ECP may lead women
not only to be less likely to use other more reliable methods, but to initiate sex at a
younger age, have more sexual partners, encourage sexual risk-taking, increase their
risk of acquiring HIV and other STIs as well (Lawrence, Rainski, Yoon & Curlin 2010;
Ehrale & Sarker, 2011; Yam et al., 2007; Blanchard, Harrison & Sello, 2005). Moreover,
1

providers in general tend to overestimate ECP's contraindications and side effects and
do not completely support its provision without prescription (Aksu et al., 2011; Ehrle
& Sarker, 2011) A study in UP has revealed that CHWs have incorrect and poor
knowledge about safe methods (Goel, Bhatnagar, Khan & Hazra, 2010).
Although limited in number, India studies show a lack of awareness among
providers about correct prescribed doses of ECP and prescribed time of use
(Kishore & Misro, 2010; Goel et al., 2010; Bhatnagar & Khan, 2011). Similar to reports
from other countries, providers in India also believe ECP is an essential component of
contraceptive services but prefer it to be distributed only through health care providers
(Tripathi, Rathore & Sachdeva, 2003; Kishore & Misro, 2010; Kumar et al., 2007). The
fear that easy ECP access will increase promiscuity and misuse is found among all
providers in India (Kishore & Misro, 2010). Another study finds that not only is ECP
awareness low among CHWs such as Accredited Social Health Activists (ASHAs) (15
percent) but only 3.3 percent had ever been supplied with ECPs (Bhatnagar & Khan,
2011).
Absence of uniform guidelines defining 'repeated use' and the number of times ECP
can be used safely within the same menstrual cycle also creates hesitation about its
provision among providers. Although the World Health Organization (WHO) (WHO
Factsheet 244, 2005) has clearly stated that repeated ECP use does not pose any serious
health risks other than minor menstrual disturbances, most providers continue to be
apprehensive about repeated ECP use. These fears and hesitations are further fuelled
by negative media coverage creating an imbalanced view of side-effects as well as
widespread misuse, especially by unmarried young girls. For example, a recent Times of
India article (July 23rd 2011, Delhi edition, Appendix), “Morning- after-pill: a medical
nightmare?” portrays ECP use by young women in Delhi along with strong opinions
against ECP by several well-known medical practitioners in the city. The article
concludes with the warning “think twice before you pop the pill,” creating ambiguity
among the readers, and such media coverage may discourage greater use and engender
unfavorable attitudes towards ECP, not only among potential users but among
providers and policy makers as well.
The Population Council undertook this study to assess the knowledge, attitudes, and
practices regarding ECP among providers in public and private facilities and
pharmacies. This study's objectives are:
·

Assessing providers' knowledge of ECP's biological mechanism;

·

Understanding providers' knowledge and attitudes about ECP's safety,
effectiveness, and availability as an OTC drug;
2

·

Identifying providers' definitions of 'repeated use' and profiling women who
are 'repeated users' of ECP.

This study's findings can be used to develop intervention programs and advocacy
strategies increasing knowledge and access to ECP.

Methodology
Quantitative survey of ECP providers
The quantitative survey was conducted in three of the four UP cities which were part
of the Urban Health Initiative (UHI) project funded by the Bill and Melinda Gates
Foundation (BMGF), as well as in Delhi, the largest city in India, with a high volume of
ECP sales. The study was initially planned in the four UP UHI cities (Lucknow, Aligarh,
Agra and Kanpur), but initial investigation and a consultative workshop indicated that
Delhi has India's largest volume of ECP sales, and so Delhi replaced Kanpur.
Subsequent surveys in the three UP cities revealed that pharmacy shops are the single
most important source of ECP supply, followed by some Family Welfare Centers, and
qualified doctors are consulted primarily in case of problems (e.g. menstrual issues or
ECP failure), so consequently only pharmacy shops were sampled in Delhi.
Lucknow, Aligarh, and Agra are of varying sizes, with populations of diverse
backgrounds and characteristics. UHI has developed an exhaustive list of public health
sector facilities, maternity and nursing homes as well as a complete list of different
types of providers and health workers in each city. UHI's lists served as a sampling
frame for the study, but in the absence of a similar systematic listing for Delhi, a
sampling frame was developed from a census of all pharmacy shops in selected areas
of Delhi.
Each city was divided into four zones—east, west, north, south—and UHI's list for
that city was used to locate providers in each zone. The sample was purposively selected
so that providers were near or in large residential areas, urban slums, or large
institutions. A total of 315 providers were selected on the criterion of ever having
provided ECP services and were interviewed October and November 2011 (Table 1).
Table 1: Sample size of quantitative study
Type of

Agra

Lucknow

Aligarh

Kanpur

Delhi

Total Sample

Qualified doctors

42

20

19

2

0

83

Pharmacists

38

55

41

8

57

199

Other providers

6

20

6

1

0

33

Total

86

95

66

11

57

315
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Qualitative survey of key opinion leaders
The qualitative survey added another dimension to its examination of ECP in India by
including in-depth interviews (IDIs) with key opinion leaders (KOLs) including leading
Ob/Gyn experts, senior officials of medical associations (such as the Indian Medical
Association and Federation of Obstetric
Table 2: Area of expertise of key
Gynecological Societies of India), senior
informants
officials of donor agencies, and senior
Number
program managers of the Ministry of Area of expertise
Health and Family Welfare of the UP and Medical fraternity1
8
federal governments. All KOLs were Government officials
7
considered to be influential both in Development organizations
3
shaping health and FP policies and Manufacturing organization
1
implementing family welfare programs Total
19
or providing resources for programs and
research. Altogether, 19 KOLs were purposively selected (Table 2).

Key findings from the quantitative survey
Providers' socio-demographic characteristics
Among 315 providers surveyed, 63 percent were pharmacists, 26 percent were qualified
doctors, and 10 percent were providers such as Auxiliary Nurse Midwives (ANMs),
Table 3: Providers' socio-demographic characteristics (percent)
Age/gender & qualification Qualified doctors Other providers Pharmacists Total
<25 years
25-34 years
35-44 years
>=45 years
Median age (years)
Male
Female
Doctor (Ob/Gyn)
Doctor (Others)
Pharmacist
Registered Nurse/Social Worker
Learnt by Practice
Total (N)

1.2
9.6
48.2
41.0
42
2.4
97.6
75.9
23.1
0.0
0.0
0.0

0.0
24.5
24.2
51.5
45
30.3
69.7
0.0
0.0
0.0
48.5
51.5

15.6
15.6
29.1
24.1
35
97.0
3.0
0.0
0.0
14.1
3.0
82.9

10.2
24.8
33.7
31.4
39
65.1
34.9
20.0
6.3
8.9
7.0
57.8

83

33

199

315

1

Medical fraternity includes members of key medical organizations and gynecologists.
The list may or may not overlap.
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staff of social marketing agencies, and counselors in FP clinics attached to large public
facilities. Two-thirds of providers were male and one-third female, due primarily to the
fact pharmacists were principally surveyed, most pharmacists were males. Pharmacists
were also, on average, seven to 10 years younger than doctors and other providers
(Table 3).

Training on ECP
Among the 315 providers in this study, out of which 19 percent had started working
before 1990, 32 percent between 1991 to 2000 and 50 percent after 2000, one-third had
been trained in FP in general and only 21 percent had been specifically trained in
providing ECP. A relatively larger proportion of doctors, compared to other providers
or pharmacists, had been trained in ECP, and more than half were trained after 2007
(Table 4).
Table 4: Percent of providers trained on FP and ECP
Qualified doctors Other providers Pharmacists Total
Ever received training in FP

67.5

63.6

12.1

32.1

Ever received training in ECP

43.4

24.2

10.6

20.6

10.8

15.2

14.2

13.4

83

33

199

315

Received brochures or any
reading materials on ECP
Total (N)

Only 13 percent of providers reported receiving any brochures or other reading
materials on ECP at any time, yet all of these providers reported having read the
materials. The sources of these materials were mostly medical representatives, with
some providers receiving them from NGOs, social marketing agencies, and the
Ministry of Health and Family Welfare.
Twenty nine percent providers (23 percent doctors, 52 percent paramedics and 28
percent pharmacists) expressed the need for brochures to provide information on ECP
to their clients whereas 71 percent providers did not feel such need as 82 percent
believed they had sufficient knowledge to provide ECP.

Knowledge of ECP mechanism
Almost half of providers believed that ECP prevents implantation, while 12 percent
felt ECP inhibits ovulation. A large proportion reported not knowing how ECP
prevents pregnancy (Table 5). The latest literature on ECP states that it does not
prevent implantation in any way (FIGO & ICEC, 2012), and thus this belief, largely
held by doctors, needs to be addressed and corrected.
5

Qualified doctors were relatively more Table 5: Providers' knowledge of ECP's
knowledgeable among providers
mechanism of action (percent)*
interviewed, probably because more of
Mechanisms of action
Total
them have received technical education
12.1
on ECP, whereas pharmacists were the Inhibits ovulation
46.3
least knowledgeable. It is important to Prevents Implantation
3.5
note that 61 percent of pharmacists did Induces abortion
not know how ECP works. Almost all Kills sperm
0.3
providers (96 percent), however, Do not know
42.5
mentioned that ECP needs to be taken Total (N)
315
within 72 hours of unprotected sexual
intercourse, largely because of the *Percentages may not add to 100 because of
guidelines for administration by multiple responses
healthcare providers of ECPs issued by India's Ministry of Health and Family Welfare,
which states “emergency contraceptive pills must be preferably taken within 72 hours
of an unprotected act of intercourse, the earlier the better” (MoHFW, 2008). However,
WHO's guidelines state that ECP can be taken within 120 hours. Following MoHFW
guidelines, national advertising (when permitted) also endorsed ECP use within 72
hours rather than 120 hours.
Figure 1: Providers' knowledge of ECP's mechanism (percent)

100

96

80
61
60
40

46

39
26

23
15

20

7

1

3

5

0

0
Prevents
Implantation

Induces abortion

Inhibits ovulation

Qualified doctors

Other providers

Do not know

Pharmacists

A question on whether providers thought ECP is an abortifacient revealed that twothirds knew ECP is not an abortifacient, while 16 percent thought it is; 18 percent were
unsure. Variations according to provider type were discernible; 90 percent of qualified
doctors and 72 percent of other providers said ECP is not an abortifacient, while only
6

55 percent of pharmacists knew it is not. Conversely, more pharmacists (20 percent)
than other providers (12 percent) and qualified doctors (10 percent) believed it is an
abortifacient, with one quarter of pharmacists unsure.
Women eligible for ECP
Table 6: Providers' opinions on who can use ECP (percent)*
Type of women

Qualified doctors

Other providers

Pharmacists

Total

Married women

78.3

90.9

79.4

80.3

unmarried women

60.2

39.4

61.8

59.0

Rape survivors

20.5

6.1

3.0

7.9

Any women

24.1

12.1

17.1

18.4

Others

0.0

0.0

1.0

0.6

Do not know

0.0

0.0

1.5

1.0

Total (N)

83

33

199

315

Adolescent/

*Percentage adds to more than 100 because of multiple replies

Only 18 percent of providers mentioned that any woman is eligible to use ECP.
Although more than half (59 percent) of providers said adolescent or unmarried
women could use ECP, a large majority (80 percent) felt married women are most
eligible for using ECP (Table 6).
Table 7: Providers' opinions on circumstances when ECP
is appropriate (percent)
Circumstances

Qualified doctors

Other providers

Pharmacists

Total

Rape or sexual

26.5

9.1

11.6

15.2

Infrequent/unpredicted sex 61.4

60.6

51.8

55.2

Engaged in sex work

7.2

3.0

9.0

7.9

Unprotected sex

41

27.3

15.1

23.2

Living as refugee/in conflict 7.2

6.1

1.0

3.2

Contraceptive failure

12

12.1

6.5

8.6

Others

2.4

0.0

1.5

1.6

Do not know

0.0

0.0

0.5

0.3

Total (N)

83

33

199

315

7

Further questioning on the circumstances when ECP is appropriate shows that
providers accept a number of situations in which ECP could be useful and appropriate
(Table 7).
When asked whether there should be a minimum age for ECP provision, most
providers (73 to 94 percent) favored minimum age restriction for ECP (Table 8).
Table 8: Providers' view on minimum age for ECP (percent)
Qualified doctors Other providers Pharmacists Total
Should there be

Yes
No

84.3
12.0

93.9
3.0

73.5
17.0

78.5
14.2

Cannot say

3.6

3.0

9.5

7.3

Total (N)

83

33

199

315

a minimum age
restriction
for ECP?

When asked further on what age should be considered minimum, answers ranged from
14 to 45 years. (Table 9) Only approximately 14 percent of providers overall, more so
among pharmacists (17 percent), felt no need for age restrictions.
Table 9: Providers' view of minimum age for ECP use (percent)*
Minimum age for ECP

Qualified doctors Other providers Pharmacists Total

14 - 18 years

27.1

29.0

49.0

40.5

19 - 24 years

28.6

41.9

35.4

39.3

>=25 years

24.3

29.0

15.0

19.8

70

31

147

247

Total (N)

*Based on responded who favored age restriction for providing ECP

Over 40 percent of respondents mentioned the ages of 14 to 18 as minimum age for
ECP provision, while an almost equal proportion (39 percent) recommended 19 to 24
years; around 16 percent suggested the age of 25. Disintegrated data show that the
majority (32 percent) of providers believed the age of 18 should be the minimum for
providing ECP; interestingly, 18 is also the minimal legal age of marriage for girls.
Another one-fifth recommended 20 years as the minimum age for providing ECP.

8

Safety and effectiveness of ECP and contraindication knowledge
The vast majority of providers believed ECP is safe and effective in preventing
pregnancy (Table 10):
Table 10: Providers' opinions of ECP's safety and effectiveness (percent)
Opinion

Qualified doctors

Other providers

Pharmacists Total

Safety
Believed ECP is safe

88.0

97.9

84.3

85.7

Effectiveness
Very effective

72.3

81.8

86.8

82.4

Somewhat/not
effective

26.5

12.1

7.6

13.1

Do not know

1.2

6.1

5.6

4.5

Total (N)

83

33

199

315

Questions about ECP's medical contraindications revealed various misconceptions
and a lack of correct knowledge among providers. According to WHO's Medical
Eligibility Criteria, ECP is safe in all conditions, except pregnancy (WHO, 2009). Less
than 2 percent of providers stated that there are no conditions under which ECP is
unsafe, and many doctors and other paramedics held misconceptions that ECP cannot
be taken by women suffering from heart disease or who are breastfeeding (Table 11).
Over one third of providers, including over half of pharmacists, reported a lack of
knowledge on ECP medical eligibility criteria.
Table 11: Knowledge of ineligibility criteria (ECP use) (percent)*
Condition
No medical conditions
Pregnancy
Liver diseases
Heart diseases
Breastfeeding
Weakness/nausea/lack
of hemoglobin/others
Do not know
Total (N)

Qualified doctors Other providers Pharmacists Total
3.6
59.0
45.8
37.3
26.5

0.0
48.5
33.3
42.4
15.2

0.5
31.2
10.1
12.6
6.0

1.3
40.3
21.9
22.2
12.4

1.2
0.0

6.1
30.3

3.5
52.8

1.9
36.5

83

33

199

315

*Percentages add more than100 because of multiple responses

9

Knowledge of side effects
Sixty percent of the providers (90 percent doctors, 67 percent paramedics and 46
percent pharmacists) said that ECP has no side effects. Providers reported light vaginal
bleeding (66 percent), fatigue (35 percent), nausea (33 percent), vomiting (26 percent),
abdominal pain (15 percent), and headache (15 percent) as possible short term side
effects or do not know.

Provider attitudes of ECP provision as OTC or prophylactic drug
A little more than half (55 percent) of the providers agreed that women should be
provided ECP as prophylactic so that it could be used when required while 26 percent
opposed it (Table 12). However, more doctors than other providers and pharmacists
did not support providing ECP on a prophylactic basis. A logistic regression analysis
showed that male providers were three times more likely than female providers
(OR=3.51, p<0.05) to support provision of ECP on a prophylactic basis, as were
younger providers (OR =1.93, p<0.01), those who had ever received training in FP
(OR=1.99, p<0.05) and those who had ever received any brochures or other
educational materials on ECP (OR=2.37, p<0.05). Those who opposed the provision
of ECP as prophylactic had fear that it may increase its misuse either to use it as a
regular method or increase premarital sex and promiscuity.
Table 12: Provider attitudes and beliefs about ECP access and
availability (percent)
Qualified doctors Other providers Pharmacists Total
Should
women be
provided
with EC in
advance
of sex?

Yes

48.2

57.6

58.1

55.4

No

42.2

27.3

19.7

26.4

Do not
know

9.6

15.2

22.2

18.2

29.3

39.4

60.6

50.2

67.1

60.6

34.3

45.7

1.2

0.0

0.5

0.6

2.4

0.0

4.5

3.5

83

33

199

315

Yes
Should EC
No
be available
It depends
OTC without
It is already
prescription?
an OTC drug
Total (N)
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A similar probing on whether ECP could be provided OTC shows that more doctors
and other trained providers than pharmacists were against provision of ECP as an
OTC drug. A logistic regression analysis showed that male providers were three times
more likely than female providers (OR=3.5, p<0.01) to support availability of ECP as
an OTC drug. No other characteristics showed any significant difference on provision
of ECP as an OTC drug, though generally less than one-third of the doctors supported
provision of ECP as an OTC drug.

Access, stock out and other challenges in providing ECP
Most (97 percent) providers were of the opinion that ECP is easily accessible to all
women who want to buy it. However a few felt that cost (9 percent), lack of awareness
(5 percent) and shame or hesitation (2 percent) could pose as barriers to access for
some women.
Slightly less than half (44 percent) of providers, mainly from NGOs and urban public
health FP clinics, as well as pharmacists mentioned occasional stock outs, while 35
percent of all providers said they never experience any stock outs. Ninety-two percent
of providers said they do not have any ECP supply problems. However, only 30 percent
of providers felt all ECPs currently available in the market are of good quality, and
32 percent felt ECP's current cost is affordable.

Preferred ECP providers
When asked who should provide ECP, the spontaneous answers mentioned most
frequently were; qualified doctors (96 percent), followed by pharmacists (63 percent).
Only a quarter of providers interviewed mentioned nurses or midwives, and still a
smaller percent (16 percent) mentioned CHWs or local TBAs or village doctors
(5 percent) as preferred sources of ECP.
A separate direct question on whether CHW/AWW should be allowed to provide ECP,
53 percent doctors, 36 percent other providers and 19 percent pharmacists were not in
favor of CHWs/AWW providing ECP because it may increase its misuse (43 percent),
many do not have adequate knowledge of ECP and need prior training (34 percent) etc.
In rural areas, CHWs such as ASHAs and (unqualified) village doctors could play a
significant role in ensuring easy ECP accessibility to all who need it. Nevertheless, this
study's findings show that more than half of doctors are still resistant to ECP provision
through CHWs or other non-medical providers.
Bivariate analysis further suggests that a significantly higher proportion of male
providers (74 percent) than female providers (46 percent) agree with making ECP
available to all women through CHWs (z test, p<0.01).
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Characteristics of ECP seekers
Most providers mentioned that the majority of women seeking ECP from them are
between 20 to 29 years old, with one-third of providers reporting women aged between
30 and 39 years old (Table 13). Ten percent of providers reported providing ECP to
women under 19, primarily by pharmacists. As to be expected with these age profiles,
the majority of providers reported most ECP clientele as married, while nearly half
reported unmarried or student clientele. A small proportion of providers also
mentioned men approaching them for ECP information or other services.
Table 13: Impressions of providers who use ECP (percent)*
Age range seeking ECP

Qualified doctors Other providers Pharmacists Total

<=19 years

1.2

3.0

15.6

10.5

20-29 years

68.4

74.2

81.9

77.7

30-39 years
>=40 years

39.2
0.0

58.1
6.5

31.7
2.5

36.2
2.3

Women of all ages

2.5

0.0

6.0

4.5

Total (N)

79

31

199

309

ECP Seekers' Status
Married women

68.4

87.1

55.8

62.1

Students/unmarried women

20.5

30.3

60.3

46.7

Women of all ages

15.2

3.2

28.1

22.3

Men

5.1

3.2

13.6

10.4

Do not know

2.5

0.0

2.5

2.3

Total (N)

79

31

199

309

*Based on those currently providing ECP

When asked about the characteristics of repeat ECP users, only 9 percent providers
said that they are different from single users, 41 percent said no and 50 percent said
cannot say or don't know. Some of the different things about ECP users reported were;
they seem physically unfit (16 percent), always look tired (13 percent), are unaware of
repeat use side effects (16 percent), have menstrual problems (26 percent), have
multiple sex partners (13 percent) etc.

Attitude towards sexual and contraceptive behavior ECP user's
The providers were asked various questions on their perception of how ECP could
influence contraceptive and sexual behavior of women. Around half of the providers
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interviewed believed that easy access to ECP would increase the promiscuity of women
and men. Still lower (66 percent) felt that it could encourage premarital sex. Fifty three
percent doctors, 55 paramedics whereas a striking 74 percent pharmacists said that
ECP users engage in premarital sex. Other risk behaviors mentioned by above one
fourth of the providers include engagement in premarital sex and belief that easy
access will increase promiscuity. About one third also felt that some couples might start
using as a substitute to other regular family planning methods. (Table 14).
Table 14: Attitudes of providers towards ECP user's sexual
behavior (percent)
Attitude

Qualified doctors Other providers Pharmacists Total

Believed easy access will
increase promiscuity

45.1

59.4

46.0

47.1

risky sexual behaviors

18.3

24.2

28.3

25.2

Have more sexual partners

25.9

39.4

27.2

28.2

transmitted infections

29.3

24.2

28.3

28.1

Engage in premarital sex

53.1

54.5

73.7

66.3

Substitute other methods

39.0

30.3

31.8

32.9

83

33

199

315

Increase participation in

Have sexually

Total (N)

Repeated use
More than three-fourths of doctors, along with almost half of other providers and one
third of pharmacists, felt ECP should not be used repeatedly in the same menstrual
cycle. Large proportions of pharmacists and providers other than doctors did not
know whether ECP could be used repeatedly in the same menstrual cycle
(Figure 2).
Among the 41 providers who felt ECP could be used more than once in the same cycle,
the majority recommended a limit of two times during the same menstrual cycle. About
three-fourths (72 percent) of pharmacists and more than half (57 percent) of doctors
believe that “many women” use ECP repeatedly.
Among the providers, most (46 percent) either did not favor the use of ECP several
times within the same menstrual cycle or were not sure (40 percent). Only 14 percent
(N=44) approved its repeat use in the same menstrual cycle. Out of 44 who approved
13

repeat use, 21 approved two times, 16 more than two times while 7 were not sure of the
number. Those who disapproved repeat use of ECP in the same menstrual cycle, most
of them were doctors (82 percent).
Figure 2: Providers' opinions on repeated use within
one menstrual cycle (percent)
100

78

80

40
20

57

52

60

36

31
18

12

13

4

0
Yes

No

Qualified doctors

Don't Know

Other providers

Pharmacists

An analysis by category of providers shows that most (78 percent) doctors disapproved
repeat use of ECP (i.e. use more than once in the same menstrual cycle). The
corresponding figure for paramedics was 52 percent, 32 percent for pharmacists.
However, those who were not sure whether ECP could be used repeatedly within the
same menstrual cycle were largest among pharmacists (13 percent) followed by doctors
(7 percent) and no paramedics.
Two-thirds of pharmacists (131 of 199) have provided ECP to the same woman more
than once, but not necessarily in the same cycle, while only 16 percent of doctors (out
of 83) and 24 percent of other providers (out of 33) reported doing so. Furthermore,
over half (56 percent) of all providers said a small proportion (10 percent) of women
who come to them have taken ECP before. A substantial proportion (14 percent) of
the 131 pharmacists reported that more than 30 percent of women they serve have
received ECP from them more than once (Table 15).
Table 15: Percentage of women buying ECP more than once (percent)
Percent
1-10
11-20
21-30
>=31
Total (N)

Qualified doctors Other providers Pharmacists Total
84.6
7.7
7.7
0.0
13

75
12.5
12.5
0.0
8
14

52.7
26.7
6.9
13.7
131

56.6
24.3
7.2
11.8
152

Need for guidance on repeated use: Slightly less than half (44 percent) of providers
felt there should be guidance on the number of times a woman could use ECP in the
same month, but opinion varied widely; 70 percent of doctors, 49 percent of other
providers, and 33 percent of pharmacists believed guidance on repeated use should be
provided.

ECP users' preferred brands
Figure 3 shows, among different ECP brands on the market, Unwanted-72 (82 percent)
and I-pill (74 percent) are the two most commonly provided.
Figure 3: Types of ECP dispensed by providers (percent)*
100

82

80

74

60
40

21

19

20

4

7

6

0
Unwanted 72 I-Pill

Unwanted Pill 72

Norlevo ECP Pill

Others

*Percentages may not add to 100 because of multiple responses: Based on *309
currently providing ECP.

Table 16: Service and information provided to customers requesting
ECP (percent)*
Information provided
Simply ECP
General information
How to use
When to use
About side effects
Counsel on FP
Counsel on STI/HIV/
respond/refer to
other services
Total (N)

Qualified doctors Other providers Pharmacists Total
2.5
51.9
46.8
53.2
34.2
17.7

12.9
54.8
32.3
35.5
22.6
3.2

93.5
4.5
2.5
2.0
1.0
0.5

62.1
21.7
16.8
18.4
11.7
5.2

16.5

9.7

2.5

6.8

79

31

199

309

*Based on those currently providing ECP
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Information provided to customers requesting ECP
As seen in Table 16, 9 out of 10 pharmacists reported simply providing ECP to
customers. Half of doctors said they provide general information on ECP, and were
more likely than other providers and pharmacists to explain when and how to use ECP,
its various side effects, and to counsel them on other FP methods

Provider suggestions for increasing ECP knowledge
A large majority (80 percent) of providers have observed a need for more media
campaigns increasing public awareness of ECP. Providers recommended more
advertisements on television (42 percent), mid-media campaigns, and meetings or
posters (19 percent) to build ECP's image as backup support for temporary FP
methods. Awareness campaigns disseminating accurate ECP knowledge through
health workers and doctors were also suggested.

Findings from key opinion leaders
Knowledge of mechanism of action
All 8 gynecologists knew ECP's mechanism of action, stating that ECP works by
delaying or inhibiting ovulation, as is reflected in the following quote:
“The precise mechanism of how ECP works in a particular case is unknown. The action of
ECP depends on time taken (after unprotected sex) and the stage of menstrual cycle. The
mechanisms of action are that ECP delays ovulation, thickens the cervical mucus, directly
inhibits fertilization and alters transportation of egg and the sperm.” —Senior
gynecologist, public hospital
Uncertainty and ambiguity about ECP's mechanism of action persists among
providers; for instance, ECP's effect if taken after ovulation or implantation was
unclear to many. One doctor stated:
“The exact mechanism of action is not known. But it mainly prevents ovulation and it
depends what day of a menstrual cycle ECP is taken.” —Senior official, Indian
Medical Association
Most KOLs (8) clearly mentioned that ECP is not an abortificant. From the
discussions, it seems that none of the KOLs mistook ECP as an abortificant.

Safety
All 19 KOLs regarded ECP as safe, with eight stating that ECP is safe but with minor
side effects:
16

“There are no health hazards with this pill, because it is a progesterone pill; and progesterone
is a hormone in the body. You will not have any major problem if you take EC, apart from
menstrual irregularity and maybe some breast tenderness and abdominal pain.” —Senior
official, National Family Welfare Program
“There are not major issues concerning safety, except that some clients may experience minor
side-effects, but there are no major side-effects.” —Program manager, international
donor agency

Effectiveness
Six KOLs stated that ECP's effectiveness is more than 90 percent, with two stating
more than 80 percent effectiveness, and one mentioning 60 to 80 percent effectiveness;
the remainder mentioned that ECP is “very effective” but did not give an exact number.
Six medically-trained informants, however, mentioned that ECP's effectiveness varies
according to whether it is taken before or after ovulation, and how long after sex:
“The effectiveness of ECP is time bound. If you take it in the first 24 hours it is very effective
and if you take it in the next 24 hours it is less effective. In general if you take it within 72
hours, I would say it is 85 percent effective.” —Senior gynecologist, private hospital

Attitudes towards ECP
Appropriate ECP use: Eight of 19 KOLs stated that the most common situation in
which ECP could be used was contraceptive failure:
“No contraceptive method is 100 percent effective. So you need a backup method like ECP,
in case a woman misses a pill, or there is condom rupture.” —Senior gynecologist,
public hospital
ECP was also regarded as appropriate for women who have infrequent sexual
intercourse:
“It is a better option for women whose husbands are migrants.” —Program manager,
international donor agency
“I think unmarried girls who are exploring their sexuality and having infrequent sex with
their boyfriends can use it.”—Senior gynecologist, private hospital.
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Less than half (7 of 19) felt ECP is appropriate for all women, irrespective of marital
status and age:
“There is nothing like that ECP is appropriate for certain kinds of women. It is for all
women.” —Senior official, Indian Medical Association
Link with promiscuity and premarital sex: Only 3 KOLs linked increasing ECP's
access to promiscuity and premarital sex. For most KOLs, it was either a
misconception, or they stated that premarital sex will occur with or without ECP,
although 6 were unsure or did not directly disclose an opinion:
“I don't think there is any correlation between promiscuity and premarital sex. People will
continue to what they want to do, but this comes as a handy tool in certain situation. ECP is
what it says … it is an emergency contraceptive pill … it is for an emergency.” —Senior
program manager, pharmaceutical manufacturing company

Belief that ECP will supplant regular contraceptive methods
Half of KOLs said increased ECP availability will not make it a substitute for regular
methods, as those using a method regularly will continue and not switch to ECP, if they
are satisfied with their regular method; the cost of repeated ECP use is higher, and it is
less effective. Two gynecologists and 1 FP officer mentioned that most clients switch to
regular methods after using ECP because of counseling, but in their experience, a few
do not transition to regular methods, primarily because of misconceptions about
regular methods, or because their partners do not want to use condoms or they find
ECP more convenient because they have irregular sexual intercourse:
“In my experience, if 10 women have taken EC and are counseled for regular method use
after that, then eight would go for regular method while two would not. The main reasons why
they do not want to use a regular method are because of misconceptions, like their weight will
increase if they take OCPs or it may cause cancer.” —Senior gynecologist, public
hospital and senior official, Indian Medical Association
Conversely, 8 of 19 KOLs expressed fear that increasing access to ECP will encourage
people to abandon regular contraceptive methods:
“Personally I am against ECP. I do feel that it would result in the substitution of mala-D
and condoms which is the best choice in case of contraceptives.” —Senior program
officer, State Health Resource Center
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Reservations among providers and program managers
Half of KOLs said that doctors and paramedics may have some reservations in
providing ECP. Three KOLs believed ECP requires a lot of counseling for
countermanding its misuse and that doctors do not have the time, so they are not able
to promote it actively:
“Our doctors have no time or habit of counseling on ECP or any health issue for that
matter.” —Program manager, national health and FP NGO
Three informants said, since ECP is easily available and accessible as an OTC drug,
women misuse it, as a regular FP method, and then rush to the gynecologist when it is
too late, either when they have become pregnant or their menstrual cycle has become
irregular. Hence, even if ECP is an OTC drug, it was felt that women who use it should
visit a gynecologist after use.
A few gynecologists and a top state family welfare officer believed ANMs should not
promote ECP because of its potential misrepresentation as an abortion pill:
“Some gynecologists have personally told me that they feel ANMs should not promote ECP
because they will misuse it. They fear that as ANMs do private practice and they may sell the
[free] ECP as an abortion pill. Nor ANMs are trained enough to provide it.” —Senior
program manager, State Family Welfare Program
Two mid-level state program officers mentioned that the Government's FP program is
perceived as low priority, even by top officials and, hence, many important activities are
neglected. For example, no one has inquired about how ECP is being introduced in
rural areas, nor how ANMs or ASHAs have been oriented on ECP. A program manager
from a large donor agency felt that government officials may also have reservations
about increasing ECP access because of moral issues or indifference about the
method:
“There might be some individuals [in the government] who might be skeptical of promoting
ECP, having the notion that it would promote promiscuity. We know that easy access of
ECP does not promote promiscuity but some government officials might be holding value
judgments. If higher level officials don't talk about it, then the message goes down the line.”
—Program manager, UN agency

Perception of KOLs about ECP users
KOLs felt that government hospital clients are mostly married women, parity one and
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two, under 30, and of lower income, with most using ECP either because of method
failure or infrequent relations with their husbands:
“Women whose husbands are not living with them come to us for ECP. Their husbands are
posted in Tamil Nadu or and come infrequently to Delhi. They use EC pills. Ours is a
government set up, most of the women who come are mostly married middle class women.”
—Senior gynecologist, public hospital and senior official, Indian Medical
Association
Clients at large private hospitals are generally single, sexually active women, between the
ages of 18 to 26 (i.e. unmarried), from the upper middle and upper class, well educated,
and with infrequent sexual intercourse. Many face menstrual-related problems or have
failed to protect themselves from pregnancy. Most unmarried women from lowermiddle income groups go to private clinics if they can afford the cost. Some KOLs
consider ECP as a symbol of women's empowerment. A senior gynecologist stated:
“I believe it is a very safe product and it empowers the woman and it's a felt need. They only
come to me when they face some problem” —Senior gynecologist, private hospital

Attitudes towards repeated use

Table 17: Definition of repeated ECP use,
reported by key opinion leaders
Definition of repeated use: As
shown in Table 17, over one-third of
Number of times in a month Frequency
KOLs could not say how many times
qualifying as repeated use
ECP can be taken in a menstrual cycle
1
5
before considered as repeated use.
2
4
Almost all KOLs interviewed were
3
3
concerned about repeated use. They
Can't
Say*
7
were of the view that ECP is for
Total (N)
19
emergency and should be a last effort to
protect from unwanted pregnancy.
*Includes 1 missing case

Fear of ECP repeated use: One of the biggest concerns often expressed, with as
many as 13 of the 19 KOLs expressing serious concern, is that ECP is not being used as
an emergency pill, nor is it advertised or promoted as such:
“If a woman is taking ECP five times it means she needs to use a regular contraceptive. The
amount of progesterone taken in five times of ECP use is more than the one month's pack of
OCP. The client needs to understand this; moreover, suspecting unwanted pregnancy five
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times a month means a lot of stress and tension. If she is taking it once every month and then
it is not an emergency either. ECP is for real emergency.” —Senior gynecologist, public
hospital and senior official, medical association
“An emergency does not repeat frequently. If you put your hand in the fire, you don't do it
again, do you? Why talk about repeat use? We can't keep talking about how many times to
use it repeatedly. You can't get in to an emergency every now and then. We have to talk about
ECP in a different fashion. This is an emergency pill- the message should be to use it during
an emergency and then go on to a routine method.” —Senior official, National Family
Welfare Program

Over the counter ECP provision
Five KOLs voiced concerns about making ECP an OTC drug:
“I strongly feel that ECP should be distributed only through doctor's prescriptions. It should
not be available over the counter for anyone to buy. That is how it is being hugely misused.
Anyone anytime could go and ask and buy it from a chemist any number of times.”
—Senior program officer, State Health Resource Center
“Repeat use of ECP is a concern when we are trying to expand the use of OCPs and
condoms.” —Program manager, international donor agency
Gynecologists reported that women come to them either with side effects (irregular
bleeding) or pregnancy, as it is easily available as an OTC drug, they may use it regularly.
Gynecologists' main concern is their lack of opportunity for counseling women since
ECP is an OTC drug. As a gynecologist put it:
“My only issue is that there should be a rider on ECP pack that the client should follow up
with a gynecologist within 15 days of taking it, and then we can counsel women on the failure
rates. What usually happens is that it is a progesterone pill and the user has a little bit of
bleeding and confuses it as a normal period. But actually they have missed their period and
when they come to us, they come with an advanced pregnancy.” —Senior gynecologist,
private hospital
Four KOLs said that if ECP is an OTC drug, public awareness about its proper use is
needed. Providers should be adequately trained and ECP packaging should be properly
informative or a proviso should recommend users see a gynecologist after selfadministering ECP.
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Could ECP help decrease abortions?
Many gynecologists (6 of 9) said it seems logical that increasing ECP's access could
have led to a decline in abortions; they felt sure that the number of surgical abortion has
decreased but did not have supporting statistics. For example:
“The number of young girls who used to come for abortion has declined. In my own clinic,
there used to be two to three girls every week with unwanted pregnancy for abortion and they
would be 10 to 12 weeks pregnant. Now in a month we hardly see one such girl. So ECP has
prevented unwanted abortions” —Senior gynecologist, famous private hospital
“Surgical evacuations have gone down a lot. One is because of ECP and second because we
are giving them medical abortifacient. The number of surgeries we are doing has drastically
dropped. But we cannot say if it is because of ECP or the MTP pill.” —Senior
gynecologist, private hospital

Supply, demand, and access
Barriers to women's access: Five KOLs stated that there are no barriers to women's
ECP access:
“Getting ECP is not a problem as it is an OTC drug. You can go to an unknown chemist if
you want privacy. Even the cost [of Rs. 100] is not much.” —Senior gynecologist,
public hospital
Many KOLs (7) believe the main barrier is a lack of real ECP knowledge and its correct
use. Some said that there is no awareness among rural women that ECP exists. Three
informants mentioned that, in smaller towns and villages, the fear and stigma
associated with acquiring ECP also poses a barrier:
“There is stigma and fear attached to access EC. If a woman wants to get ECP and does not
want her husband to know, then how will she ask for it? She will think what people will say.
It is important to take health workers in confidence.” —Senior official, Indian Medical
Association
Two KOLs mentioned there has not been enough providers training, which prevents
access, while another 2 said cost also restricts ECP access.
Provider challenges: Several challenges were reported, including lack of knowledge,
inadequate training, difficultly in identifying clients, and counseling them, meager
motivation, and poor supply in public clinics. Over half the KOLs said providers,
including doctors, pharmacists, ASHAs and ANMs, do not have accurate ECP
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knowledge nor have been adequately trained to provide ECP and related services; it
should be noted that no ECP training was offered when introduced by the
Government:
“All the training guidelines have been developed for ASHAs, but somebody has to take the
pain to train them and explain them about ECP and monitor usage. You are talking about
eight lakhs ASHAs and thousands of trainers, so training looks like an issue.”
—Program manager, UN agency
“None of the ANMs have got any training on ECP, they learnt by practice and by working
with us and discussing with us. There has been no training given to any doctors or ANMs or
to the pharmacists. It is also not there in the service guidelines of doctors or ANMs. Then
how will anyone know about the exact or the appropriate use of ECP?” —Gynecologist,
urban family planning clinic
“The pharmacists are not trained and they just give ECP on demand. How will they counsel
and give correct information to the client?” —Senior gynecologist, private hospital
Four program managers reported that ECP, and even FP, provision has not been a focus
of the Ministry of Health and Family Welfare:
“Family planning has never been a focus. No high profile official wants to inaugurate meetings
of the family planning program. ECP has not been a focus since it was never there in supply.
Now it has come back and the supply is picking up. People are asking for it. FP is low priority
in the State health system” —Senior program manager, State Family Welfare
Program
Five informants mentioned that there is little chance for ECP counseling, either
because doctors are not in the habit or because it is purchased OTC without doctor
consultation. Nine KOLs mentioned special challenges for increasing access to ECP in
rural areas:
“In rural areas people have to travel 10 kms to reach a pharmacist, unlike in urban areas.
There is no bus or any transport to reach there. Cost is also a barrier. Also there is a certain
degree of anonymity in urban areas but in rural areas everyone will come to know if you are
buying ECP. It is a challenge to reach these groups.” —Program manager, national
health and FP NGO
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Opinions on government program to make ASHA the depot holder of
ECP
In general, program managers welcomed GoI's pilot project to make ASHAs
contraceptive depositories for community supply at a small cost. While one informant
believed that charging Rs.2 for ECP from ASHAs (instead from health facilities for
free) may compromise access for those in dire need of ECP who may not be able to buy
it. Another informant said that the price is not much and that making ASHAs
depositories will increase ECP accessibility. The Government's ASHA pilot project was
seen as focusing on spacing methods:
“For the first time the government is going with a spacing package. It is a deviation from the
earlier approach which focused on permanent methods. The supply will be at the district level
and will not be withdrawn from there. The cost of Rs.2 for ECP is not much- money is not a
big dampener. But training has to be done, a communication plan should be there and proper
monitoring has to be done.” —Program manager, UN agency

KOLs' suggestions for increasing
access

Box: Key recommendations for

increasing ECP access
As shown in Box, the key recommenda· BCC plan including mass media
tions for increasing ECP access were
· Adequate training of pharmacists
the development of a communication
· Adequate training of ASHAs
plan and use of mass media for
·
Regular and frequent updates on ECP for
disseminating information to the
government officials
public, particularly on repeated use,
· ECP should be included in refresher
side effects, and emergency use only. It
courses for ANMs
was also suggested that doctors,
· Sensitize mass media to project ECP
pharmacists, and CHWs providing
correctly.
ECP need to be adequately trained.
Other suggestions for increasing access
to ECP include frequent ECP updates circulated among government officials,
inclusion of ECP information in all ANM and ASHA refresher courses, partnerships
with rural private providers, and other forms of media including door-to-door
counseling, IEC, and VHNDs for disseminating ECP information. The focus should
be on adolescents and young people who can be reached through programs, sex
education classes at school, the mass media and other forms of media (e.g. internet).
Only one KOL said that ECP should be made available only on doctor's prescription
and not as an OTC drug.
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KOLs' suggestions for advertising
The key advertising message, according to 13 KOLs, should be ECP's use for
emergency situations only. ECP should be promoted along with other contraceptive
methods and not as a separate method, in mass media. It should be a backup to method
failure and with repeated use's side effects given more attention. KOLs believe sex
should be projected as a responsible and not casual activity for which ECP is readily
available; informants said that this was one of the reasons why recent commercial
advertisements were banned or withdrawn. Central government officials stated that
ECP is being advertised in mass media, but state officials said it has yet to begin at their
level. Many KOLs reiterated that a responsible role by media can help increase correct
ECP information and knowledge; the media needs to be sensitized:
“[Initially] ECP was being advertised as something very attractive to use. But it is not like
that. The way we create awareness, educate and counsel the public and the providers is very
important. It should be done in such a way that it is something that should be used only in
accidents or emergency. It should not be advertised as a contraceptive method.” —Senior
gynecologist, public hospital
“The media is glorifying sex and making it sounds like a casual thing. It projected 'let's go
have sex and take ECP after that'. They did not give the whole message and trivialized issue
of unwanted pregnancy and risk of unsafe sex. Creating hype is the easiest thing to do. The
media needs to show sex as a responsible behavior. We need sustained mass media, mid media
and IPC to spread correct information to the public.” —Senior official, National
Family Welfare Program

Conclusions and recommendations
This study's findings show that most providers, including doctors and some KOLs,
were incorrectly informed about ECP's mechanism of action. Many doctors still
believe ECP prevents implantation and cannot be used by breastfeeding women or
those with heart problems. Pharmacists, who provide most of India's ECP, are the
most uninformed group of providers. As a consequence of pharmacists' lack of
knowledge of ECP, they do not provide any information on it to customers, in addition
to fear of embarrassing customers because of lack of privacy in their shops, in addition
to lacking time for any real client counseling. It is encouraging that all categories of
providers and KOLs generally believe ECP is safe and effective for preventing
unwanted pregnancies. Most providers are still reluctant to provide or promote ECP as
a prophylactic, and most KOLs said ECP is only appropriate for emergencies such as
contraceptive failure or infrequent or isolated sex acts. Most providers believe ECP is
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best and most appropriate for married women and that a minimum age restriction of
18 to 20 should be instituted for ECP provision. The stigmatization of ECP makes its
accessibility difficult and belies a general fear among providers of 'misuse' by young,
unmarried women.
Among all providers, ambiguities persist about the definition of repeated use during
the same menstrual cycle. In general, repeated use of ECP was not acceptable among
providers, including pharmacists, the primary providers of ECP, who believe many
women use it repeatedly; pharmacists, compared to other providers, report more
frequent, repeated ECP use by their clientele. Correct ECP use, including as a back-up
method, depends largely on how knowledgeable users are, and in the absence of such
knowledge incorrect use may cause menstrual disorder or pregnancy prevention
failure. Service guidelines are necessary for accurate and adequate information on
ECP's mechanism of action, as well as its use as a back-up or emergency method, its
frequency of use in the same menstrual cycle, and its lack of effectiveness and possible
side effects if used repeatedly.
Most KOLs supported ECP's continuation as an OTC drug, but some KOLs and
many qualified doctors had reservations about promoting or mainstreaming ECP with
other contraceptive methods; these same providers were also less supportive of its
OTC status as well as its distribution by CHWs such as ASHAs. In general, doctors do
not agree with ECP's de-medicalization and would prefer it to be a prescription drug,
which is a matter of concern requiring advocacy to influence and change their
opinions. Disseminating accurate ECP information among all provider categories
could be achieved, to some extent, by including ECP in the training curricula of all
doctors, nurses, and pharmacists. Periodic seminars and presentations through the
official organizations of different providers such as the Indian Council of Medical
Research (ICMR), Federation of Obstetrics and Gynecological Societies of India
(FOGSI), or Indian Pharmacists Association could also help mitigate misconceptions
about ECP and improve dispensing practices for it.
The most important rationale for ECP's introduction and funding is that it's easy access
and correct use will reduce unwanted pregnancy and abortion. IDIs with doctors,
however, belied their uncertainty about whether women are benefiting from ECP.
Several senior gynecologists mentioned that ECP has helped reduce the rate of
unwanted pregnancies and abortions, especially among young women, but they also
stated this decline could be attributed to easy availability of medical abortion pills.
Some providers and KOLs felt ECP's benefits are undermined by irresponsible
advertisements that result in misuse. There is a general feeling that young people are
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becoming more open to premarital sex, in which case ECP can prevent unwanted
pregnancy, but it can be misused easily with increasing frequent use, for example half of
the providers felt that easy accessibility may also lead to promiscuity. Most KOLs
believe the relationship between ECP use and promiscuity is a misconception, although
some do believe they are related. There is also concern that ECP may be substituted for
regular contraceptive methods, but many KOLs believe it can act as a bridge to regular
methods, if promoted correctly.
Manufacturers, pharmacies, and some KOLs want the Government to rescind the ban
on ECP advertising but emphasize that advertisements should emphasize ECP's
“emergency only” use. ECP advertisements should emphasize its emergency
utilization, when another method fails, rather than as a separate method. Several
experts suggested responsible advertising through mass media and promoting ECP
along with other contraceptive methods would help improve its perception as a backup method among the general public and reduce misuse. Emphasizing that 'any woman
in an emergency situation can use ECP' will also help reduce its stigma and the labeling
of its users. As part of corporate social responsibility, medical representatives of
different ECP manufacturing firms in regular contact with pharmacists could play a
significant role in educating pharmacists about ECP and its overall role as an emergency
device for protecting against unwanted pregnancy, and not as a regular method or
abortifacient.
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This report provides an analysis of the study on the knowledge, attitudes, and
practices regarding the emergency contraception pill (ECP) among providers in
public and private healthcare facilities and pharmacies.
The ECP is a unique method of contraception because it can be used post coital.
However, its use has remained limited to urban areas, with very little penetration in
rural areas. Considering the high rate of unwanted pregnancy in India, the ECP was
introduced in the National Family Planning Program in 2002 and made Over the
Counter in 2005. There have been newspaper statements by medical fraternity
opposing ECP use on various grounds including side effects and its social impact
such as promiscuity. A quantitative survey of pharmacists, doctors and paramedics
was conducted in four cities of Uttar Pradesh and Delhi, qualitative in depth
interviews of experts including gynecologists, senior government employees,
officers of development organizations and an ECP manufacturing firm executive
were also conducted to complement the findings. The study was carried out with
technical and financial support from the International Consortium of Emergency
Contraception.
The survey revealed that ECP is mainly being provided to a young section of women,
by pharmacists who are not trained on ECP. Although providers believe that ECP is
safe and effective, they lack correct knowledge on the mechanism of ECP and are
often not in favor of easy availability of ECP to young and unmarried women. Higher
availability of ECP was linked to issues such as repeated use and increase in
premarital sex. The findings identify a need for educational campaigns, careful
advertising, guidelines on repeat use, advocacy to tackle negative provider
attitudes and IEC material which would have a direct bearing on policy, program
implementation to address barriers to ECP access and to improve service delivery.

